Krause M - Search Results

1

Slice2Volume: Fusion of multimodal medical imaging and light microscopy data of irradiation-injured brain tissue in 3D.

Soltwedel J, Suckert T, Beyreuther E, Schneider M, Boucsein M, Bodenstein E, Nexhipi S, Stolz-Kieslich L, Krause M, von Neubeck C, Haase R, Lühr A, Dietrich A. Soltwedel J, et al. Among authors: krause m. Radiother Oncol. 2023 May;182:109591. doi: 10.1016/j.radonc.2023.109591. Epub 2023 Feb 28. Radiother Oncol. 2023. PMID: 36858201 Free article.

2

Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.

Petersen C, Zips D, Krause M, Völkel W, Thames HD, Baumann M. Petersen C, et al. Among authors: krause m. Radiother Oncol. 2005 Mar;74(3):331-6. doi: 10.1016/j.radonc.2004.10.009. Radiother Oncol. 2005. PMID: 15763315

3

Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.

Krause M, Ostermann G, Petersen C, Yaromina A, Hessel F, Harstrick A, van der Kogel AJ, Thames HD, Baumann M. Krause M, et al. Radiother Oncol. 2005 Aug;76(2):162-7. doi: 10.1016/j.radonc.2005.06.032. Radiother Oncol. 2005. PMID: 16024114

4

Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?

Yaromina A, Hölscher T, Eicheler W, Rosner A, Krause M, Hessel F, Petersen C, Thames HD, Baumann M, Zips D. Yaromina A, et al. Among authors: krause m. Radiother Oncol. 2005 Aug;76(2):206-12. doi: 10.1016/j.radonc.2005.06.019. Radiother Oncol. 2005. PMID: 16024121

5

Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.

Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, Haase M, Petersen C, Raleigh JA, Quennet V, Walenta S, Mueller-Klieser W, Baumann M. Yaromina A, et al. Among authors: krause m. Radiother Oncol. 2006 Nov;81(2):122-9. doi: 10.1016/j.radonc.2006.08.010. Epub 2006 Sep 7. Radiother Oncol. 2006. PMID: 16956683

6

Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.

Yaromina A, Krause M, Thames H, Rosner A, Krause M, Hessel F, Grenman R, Zips D, Baumann M. Yaromina A, et al. Among authors: krause m. Radiother Oncol. 2007 Jun;83(3):304-10. doi: 10.1016/j.radonc.2007.04.020. Epub 2007 May 22. Radiother Oncol. 2007. PMID: 17517444

7

Effect of cetuximab and fractionated irradiation on tumour micro-environment.

Santiago A, Eicheler W, Bussink J, Rijken P, Yaromina A, Beuthien-Baumann B, van der Kogel AJ, Baumann M, Krause M. Santiago A, et al. Among authors: krause m. Radiother Oncol. 2010 Nov;97(2):322-9. doi: 10.1016/j.radonc.2010.07.007. Radiother Oncol. 2010. PMID: 20667608

8

Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression.

Gurtner K, Deuse Y, Bütof R, Schaal K, Eicheler W, Oertel R, Grenman R, Thames H, Yaromina A, Baumann M, Krause M. Gurtner K, et al. Among authors: krause m. Radiother Oncol. 2011 Jun;99(3):323-30. doi: 10.1016/j.radonc.2011.05.035. Epub 2011 Jun 12. Radiother Oncol. 2011. PMID: 21665304

9

Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo.

Gurtner K, Hessel F, Eicheler W, Dörfler A, Zips D, Heider KH, Krause M, Baumann M. Gurtner K, et al. Among authors: krause m. Radiother Oncol. 2012 Mar;102(3):444-9. doi: 10.1016/j.radonc.2011.10.013. Epub 2011 Nov 17. Radiother Oncol. 2012. PMID: 22100655

10

GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trial.

Soliman M, Yaromina A, Appold S, Zips D, Reiffenstuhl C, Schreiber A, Thames HD, Krause M, Baumann M. Soliman M, et al. Among authors: krause m. Radiother Oncol. 2013 Mar;106(3):299-304. doi: 10.1016/j.radonc.2012.12.008. Epub 2013 Jan 17. Radiother Oncol. 2013. PMID: 23333018 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,102 results

Search Page